Journal Article Summary

The article investigates the use of secondary prophylactic medications in patients who have been discharged from the hospital after experiencing a myocardial infarction, commonly known as a heart attack. This topic is significant because proper use of these medications, such as beta blockers and aspirin, can help prevent future heart attacks and improve patient outcomes. Understanding how these drugs are prescribed can highlight gaps in care and inform better practices in managing patients post-discharge.

The study involved a survey sent to general practitioners in the Northern Region of England, focusing on patients who had recently suffered a myocardial infarction. Out of 267 patients surveyed, it was found that 59% were not receiving optimal treatment, meaning they were not prescribed a secondary prophylactic drug when there were no medical reasons to avoid them. Specifically, beta blockers were prescribed significantly less often than aspirin, and a small percentage of patients received no treatment at all. The study revealed that the likelihood of receiving these medications did not depend on factors like age, sex, or the hospital where the patient was treated.

One limitation of the study is that it relied on self-reported data from general practitioners, which may not fully capture the actual treatment practices. Additionally, the findings suggest a need for improved consistency in prescribing these medications to enhance patient safety and outcomes. Patients and caregivers should discuss with healthcare professionals the importance of secondary prophylaxis after a heart attack, including any potential side effects and the necessity of adhering to prescribed treatments to reduce the risk of future heart issues.

Medical Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Eccles M., Bradshaw C.. Use of secondary prophylaxis against myocardial infarction in the north of England.. BMJ : British Medical Journal 1991. DOI: 10.1136/bmj.302.6768.91. PMID: 1671652. PMCID: PMC1668878.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]